Skip to main content
Earnings Labs
Compugen Ltd. logo

Compugen Ltd. (CGEN)

NASDAQ·Healthcare·Biotechnology

$2.04

+0.49%

Mkt Cap $198.56M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (5 analysts)

$4.50

Range $4.00$5.00

Implied Upside

+120.6%

Consensus $4.50 vs current $2.04